Chemistry-Based Functional Proteomics: Mechanism-Based Activity-Profiling Tools for Ubiquitin and Ubiquitin-like Specific Proteases

Journal of Proteome Research

Volumn 3, Issue 2, 2004, Pages 268-276

  Hemelaar, Joris ^a   Galardy, Paul J ^a   Borodovsky, Anna ^a   Kessler, Benedikt M ^a   Ploegh, Hidde L ^a   Ovaa, Huib ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Activity based inhibitor; Functional proteomics; Intein; Nedd8; Protease profiling; Suicide inhibitor; SUMO; Ubiquitin; Ubiquitin like protein; Ubiquitin specific protease

Indexed keywords

CYSTEINE PROTEINASE; GENE PRODUCT; OVARIAN TUMOR DOMAIN PROTEASE; PROTEINASE; SERINE PROTEINASE; THREONINE PROTEINASE; UBIQUITIN; UBIQUITIN LIKE SPECIFIC PROTEASE; UNCLASSIFIED DRUG;

ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SPECIFICITY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; REVIEW;

B-LYMPHOCYTES; BINDING SITES; ENDOPEPTIDASES; FEMALE; HUMANS; MODELS, CHEMICAL; OVARIAN NEOPLASMS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOME; PROTEOMICS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; UBIQUITIN;

EID: 13444275087     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0341080     Document Type: Review

References (68)

1. Eisen, M. B.; Brown, P. O. DNA arrays for analysis of gene expression. Methods Enzymol. 1999, 303, 179-205.
2. MacBeath, G. Protein microarrays and proteomics. Nat. Genet. 2002, 32, Suppl, 526-532.
3. Adam, G. C.; Sorensen, E. J.; Cravatt, B. F. Chemical strategies for functional proteomics. Mol. Cell Proteomics 2002, 1, 781-790.
4. Jeffery, D. A.; Bogyo, M. Chemical proteomics and its application to drug discovery. Curr. Opin. Biotechnol. 2003, 14, 87-95.
5. Thompson, L. A.; Ellman, J. A. Synthesis and Applications of Small Molecule Libraries. Chem. Rev. 1996, 96, 555-600.
6. Liu, Y.; Patricelli, M. P.; Cravatt, B. F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 14 694-14 699.
7. Greenbaum, D.; Medzihradszky, K. F.; Burlingame, A.; Bogyo, M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 2000, 7, 569-581.
8. Bogyo, M. et al. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homologue HslV by a new class of inhibitors. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 6629-6634.
9. Palmer, J. T.; Rasnick, D.; Klaus, J. L.; Bromme, D. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 1995, 38, 3193-3196.
10. Lennon-Dumenil, A. M. et al. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 2002, 196, 529-540.
11. Greenbaum, D. C. et al. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 2002, 298, 2002-2006.
12. Kessler, B. M.; Glas, R.; Ploegh, H. L. MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation. Mol. Immunol. 2002, 39, 171-179.
13. Mack, A.; Furmann, C.; Hacker, G. Detection of caspase-activation in intact lymphoid cells using standard caspase substrates and inhibitors. J Immunol Methods 2000, 241, 19-31.
14. Ovaa, H. et al. Chemistry in Living Cells: Detection of Active Proteasomes by a Two-Step Labeling Strategy. Angew. Chem., Int. Ed. Engl. 2003, 42, 3626-3629.
15. Hershko, A.; Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67, 425-479.
16. Jentsch, S.; Pyrowolakis, G. Ubiquitin and its kin: how close are the family ties? Trends Cell Biol. 2000, 10, 335-342.
17. Whitby, F. G.; Xia, G.; Pickart, C. M.; Hill, C. P. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J. Biol. Chem. 1998, 273, 34 983-34 991.
18. Bayer, P. et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 1998, 280, 275-86.
19. Paz, Y.; Elazar, Z.; Fass, D. Structure of GATE-16, membrane transport modulator, and mammalian ortholog of autophagocytosis factor Aut7p. J. Biol. Chem. 2000, 275, 25 445-25 450.
20. Bavro, V. N. et al. Crystal structure of the GABA(A)-receptor-associated protein, GABARAP. EMBO Rep. 2002, 3, 183-189.
21. Coyle, J. E.; Qamar, S.; Rajashankar, K. R.; Nikolov, D. B. Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding. Neuron 2002, 33, 63-74.
22. McNally, T. et al. Structural analysis of UBL5, a novel ubiquitin-like modifier. Protein Sci. 2003, 12, 1562-1566.
23. Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408, 488-492.
24. Wilkinson, K. D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 2000, 11, 141-148.
25. Wing, S. S. Deubiquitinating enzymes-the importance of driving in reverse along the ubiquitin-proteasome pathway. Int. J. Biochem. Cell Biol. 2003, 35, 590-605.
26. Wilkinson, K. D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. Faseb J. 1997, 11, 1245-1256.
27. Larsen, C. N.; Krantz, B. A.; Wilkinson, K. D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 1998, 37, 3358-3368.
28. Borodovsky, A. et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 2002, 9, 1149-1159.
29. Makarova, K. S.; Aravind, L.; Koonin, E. V. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 2000, 25, 50-52.
30. Balakirev, M. Y.; Tcherniuk, S. O.; Jaquinod, M.; Chroboczek, J. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep. 2003, 4, 517-522.
31. Evans, P. C. et al. A novel type of deubiquitinating enzyme. J. Biol. Chem. 2003, 278, 23 180-23 186.
32. Verma, R. et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298, 611-615.
33. Cope, G. A. et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002, 298, 608-611.
34. Wada, H.; Kito, K.; Caskey, L. S.; Yeh, E. T.; Kamitani, T. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem. Biophys. Res. Commun. 1998, 251, 688-692.
35. Gong, L.; Kamitani, T.; Millas, S.; Yeh, E. T. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J. Biol. Chem. 2000, 275, 14 212-14216.
36. Hemelaar, J. et al. Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins. Mol. Cell Biol., in press 2003.
37. Malakhov, M. P.; Malakhova, O. A.; Kim, K. I.; Ritchie, K. J.; Zhang, D. E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 2002, 277, 9976-9981.
38. Li, S. J.; Hochstrasser, M. A new protease required for cell-cycle progression in yeast. Nature 1999, 398, 246-251.
39. Yeh, E. T., Gong, L.; Kamitani, T. Ubiquitin-like proteins: new wines in new bottles. Gene 2000, 248, 1-14.
40. Johnston, S. C.; Riddle, S. M.; Cohen, R. E.; Hill, C. P. Structural basis for the specificity of ubiquitin C-terminal hydrolases. Embo J. 1999, 18, 3877-3887.
41. Mossessova, E.; Lima, C. D. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 2000, 5, 865-876.
42. Hu, M. et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002, 111, 1041-1054.
43. Wu, K. et al. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyperneddylated CUL1. J. Biol. Chem. 2003, 278, 28 882-28 891.
44. Gan-Erdene, T. et al. Identification and characterization of DEN1, a deneddylase of the ULP family. J. Biol. Chem. 2003, 278, 28 892-28 900.
45. Mendoza, H. M. et al. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 2003, 278, 25 637-25 643.
46. Balakirev, M. Y.; Jaquinod, M.; Haas, A. L.; Chroboczek, J. Deubiquitinating function of adenovirus proteinase. J. Virol. 2002, 76, 6323-6331.
47. Marino, G. et al. Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J. Biol. Chem. 2003, 278, 3671-3678.
48. Hemelaar, J.; Lelyveld, V. S.; Kessler, B. M.; Ploegh, H. L. A single protease, Apg4B, is specific for the autophagy related ubiquitin-like proteins GATE16, MAP1 LC3, GABARAP, and Apg8L. J. Biol. Chem. 2003, in press.
49. Kirisako, T. et al. The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J. Cell Biol. 2000, 151, 263-276.
50. Dang, L. C.; Melandri, F. D.; Stein, R. L. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 1998, 37, 1868-1879.
51. Borodovsky, A. et al. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. Embo J. 2001, 20, 5187-5196.
52. Leggett, D. S. et al. Multiple associated proteins regulate proteasome structure and function. Mol. Cell 2002, 10, 495-507.
53. Cohen, M.; Stutz, F.; Belgareh, N.; Haguenauer-Tsapis, R.; Dargemont, C. Ubp3 requires a cofactor, Bre5, to specifically deubiquitinate the COPII protein, Sec23. Nat. Cell Biol. 2003, 5, 661-667.
54. Pickart, C. M.; Rose, I. A. Mechanism of ubiquitin carboxyl-terminal hydrolase. Borohydride and hydroxylamine inactivate in the presence of ubiquitin. J. Biol. Chem. 1986, 261, 10 210-10 217.
55. Lam, Y. A.; Xu, W.; DeMartino, G. N.; Cohen, R. E. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 1997, 385, 737-740.
56. Xu, M. Q.; Evans, T. C., Jr. Intein-mediated ligation and cyclization of expressed proteins. Methods 2001, 24, 257-277.
57. Ovaa, H. et al. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. Proc. Natl. Acad. Sci., in press.
58. Bignell, G. R., et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 2000, 25, 160-165.
59. Wilkinson, K. D. Signal transduction: aspirin, ubiquitin, and cancer. Nature 2003, 424, 738-739.
60. Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003, 424, 793-796.
61. Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-kappaB signaling by deubiquitination. Nature 2003, 424, 801-805.
62. Brummelkamp, T. R.; Nijman, S. M.; Dirac, A. M.; Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424, 797-801.
63. Gavioli, R.; Frisan, T.; Vertuani, S.; Bornkamm, G. W.; Masucci, M. G. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat. Cell Biol. 2001, 3, 283-288.
64. Sakamoto, T. et al. An NMR analysis of ubiquitin recognition by yeast ubiquitin hydrolase: evidence for novel substrate recognition by a cysteine protease. Biochemistry 1999, 38, 11 634-11 642.
65. Potter, J. L.; Narasimhan, J.; Mende-Mueller, L.; Haas, A. L. Precursor processing of pro-ISG15/UCRP, an interferon-beta-induced ubiquitin-like protein. J. Biol. Chem. 1999, 274, 25 061-25 068.
66. Best, J. L. et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell. 2002, 10, 843-855.
67. Ross, S.; Best, J. L.; Zon, L. I.; Gill, G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell. 2002, 10, 831-842.
68. Scherz-Shouval, R.; Sagiv, Y.; Shorer, H.; Elazar, Z. The COOH terminus of GATE-16, an intra-Golgi transport modulator, is cleaved by the human cysteine protease HsApg4A. J. Biol. Chem. 2003, 278, 14 053-14 058.